Patrick Joseph Roberts

4 Patents

• US125277982026

  Preservation of Immune Response During Chemotherapy Regimens

  Pharmacosmos Holding A/S

  0 cites
• US122854312025

  Treatment of Rb-negative Tumors Using Topoisomerase Inhibitors in Combination with Cyclin Dependent Kinase 4/6 Inhibitors

  Pharmacosmos Holding A/S

  0 cites
• US117175232023

  Transient Protection of Normal Cells During Chemotherapy

  G1 Therapeutics, Inc.

  0 cites
• US116541482023

  Hspc-sparing Treatments for Rb-positive Abnormal Cellular Proliferation

  G1 Therapeutics, Inc.

  0 cites